Astellas is a pharmaceutical company committed to turning innovative science into value for patients. “Changing Tomorrow” is the ethos that guides everything we do.
Nephrology is an integral area of our business, building on our heritage of supporting patients with kidney disease through our commitment to the transplantation community. This work now continues with our focus on anaemia associated with chronic kidney disease (CKD).
Across our areas of therapeutic expertise, we use our agility to match scientific breakthroughs to the unmet needs of patients around the world, and the many healthcare professionals and caregivers who support them.
Astellas invests in new medicines, technologies and therapeutic areas, and builds partnerships and networks with others who share our vision to improve the future of medicine.
Astellas is working at the forefront of healthcare change and the values of patient focus, ownership, results, openness and integrity are the foundation of our culture.